Subclinical hyperthyroidism in patients with nodular goiter represents a hypermetabolic state

Experimental and Clinical Endocrinology and Diabetes

Volumn 113, Issue 2, 2005, Pages 122-126

  Kvetny, J ^a,b  

^a University of Esbjerg   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

Author keywords

Diurnal TSH variation; Oxygen consumption; Subclinical hyperthyroidism

Indexed keywords

LIOTHYRONINE; THIAMAZOLE; THYROTROPIN;

ADULT; ARTICLE; BASAL METABOLIC RATE; BONE DENSITY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPERMETABOLISM; HYPERTHYROIDISM; HYPOPHYSIS THYROID SYSTEM; MALE; NODULAR GOITER; PRIORITY JOURNAL;

BONE DENSITY; CIRCADIAN RHYTHM; ENERGY METABOLISM; GOITER, NODULAR; HUMANS; HYPERPARATHYROIDISM; OXYGEN CONSUMPTION; REFERENCE VALUES; THYROID HORMONES; THYROTROPIN;

EID: 15244342643     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-830541     Document Type: Article

References (22)

1. 3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002; 87: 1068-1072
2. Bartalena L, Martino E, Veluzzi F, Piga M, Petrini L, Loviselli A, Grasso L, Pinchera A. The lack of nocturnal serum thyrotropin surge in patients with nontoxic nodular goiter may predict the subsequent occurrence of hyperthyroidism. J Clin Endocrinol Metab 1991; 73: 604-608
3. Becker, DV. Metabolic indices. In: Werner SG, Ingbar SH (ed). The Thyroid. 3rd ed. New York, Evanston, San Francisco, London: Harper & Row, 1971: 269-291
4. Biondi B, Fazio S, Cuocolo A, Sabatini D, Nicolai E, Lombardi G, Salvatore M, Sacca L. Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1996; 81: 4224-4228
5. Brabant G, Prank K, Ranft U, Bergman P, Schuermayer T, Hesch RD, von zur Muhlen A. Circadian and pulsatile TSH secretion under physiological and pathophysiological conditions. Horm Metabol Res 1990; 23 (Suppl): 12-17
6. Crooks J, Murray IPC, Wayne EJ. Statistical methods applied to the clinical diagnosis of thyrotoxicosis. Quart J Med 1959; 110: 211-234
7. Faber J, Galløe MA. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 1994; 130: 350-356
8. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 1988; 37: 287-301
9. Kalmijn S, Mechta KM, Polst HAP, Hofman A, Drexhage AH, Breteler MMB. Subclinical hyperthyroidism and the risk of dementia. Clin Endocrinol 2000; 53: 733-737
10. Kvetny J. 3.5-T2 stimulates oxygen consumption, but not glucose uptake in human mononuclear blood cells. Horm Metab Res 1991; 24: 322-325
11. Kvetny J. The significance of clinical euthyroidism on reference range for thyroid hormones. Eur J Int Med 2003; 14: 315-320
12. Lanni A, Moreno M, Lombardi A, de Lange P, Goglia F. Control of energy metabolism by iodothyronines. J Endocrinol Invest 2001; 24: 897-913
13. Marqusee E, Haden ST, Utiger RD. Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am 1998; 27: 37-49
14. Nakabayashi K, Matsumi H, Bhalla A, Bae J, Mosselman S, Hsu SY, Hsueh AJW. Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor. J Clin Invest 2002; 109: 1445-1452
15. Robertson JD, Reid DD. Standards for the basal metabolism of normal people in Britain. Lancet 1952; 11: 940-943
16. Sgarbi JA, Villaca FG, Garbeline G, Villar HE, Romaldini JH. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. J Clin Endocrinol Metab 2003; 88: 1672-1677
17. Stott DJ, McLellan AR, Finlayson J, Chu P, Alexander WD. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at an increased risk of developing overt hyperthyroidism. Quart J Med 1991; 78: 77-84
18. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col FN, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, German C, Cooper RS, Weisman NJ. Subclinical thyroid disease. JAMA 2004; 291: 228-238
19. Toft AD. Subclinical hyperthyroidism. N Engl J Med 2001; 345: 512-517
20. Weber P, Krause U, Gaffga G, Brabant G, Manz F, Lehnert H, Schreichenmeir J, Byer J. Unaltered pulsatile and circadian TSH release in euthyroid patients with endemic goitre. Acta Endocrinol 1991; 124: 386-390
21. Weeke J. Thyrotropin and Thyroid Hormones in Normal Subjects. København, Århus, Odense: FADL's forlag, 1978: 1-62
22. Wiersinga WM. Subclinical hypothyroidism and hyperthyroidism. Netherlands J Med 1995; 46: 197-204